AI Tools Increase Low-Dose CT Lung Nodule Specificity
|
By MedImaging International staff writers Posted on 02 Feb 2021 |

Image: AI identification of lung nodule matches or bests that of trained radiologists (Photo courtesy of iStock)
Combining artificial intelligence (AI) and lung imaging reporting and data system (Lung-RADS) scores can increase CT scan specificity without reducing sensitivity, according to a new study.
Researchers at the University of Saskatchewan (Saskatoon, Canada) conducted a study that performed secondary analysis of a known data set using an AI model developed by Google in 2019, and Lung-RADS classifications from six radiologists. They then compared them to assess a representative cohort of 3,197 baseline low-dose CT screening patients. To ensure the AI algorithm matched the 91% sensitivity level achieved by the providers, the researchers determined a 0.27 AI risk-score threshold, based on a 0-to-1 scale.
The results showed that the AI-informed management strategy achieved sensitivity and specificity of 91% and 96%, respectively, while the average sensitivity and specificity of the six radiologists using only Lung-RADS was 91% and 61%, respectively. Based on the AI management strategy, 0.2% of category 1 or 2 Lung-RADS classifications were upgraded to category 3, and 30% of category 3 or higher classifications were downgraded to category 2. The minimum net cost savings, based on 2019 U.S. Medicare physician fee schedule, was USD 72 per patient screened. The study was published on January 19, 2021, in Journal of the American College of Radiology.
“Using an AI risk score combined with Lung-RADS at baseline lung cancer screening may result in fewer follow-up investigations and substantial cost savings. Specificity could rise by more than fifty percent,” concluded lead author Scott Adams, MD, and colleagues. “Additional research for other AI thresholds could also beneficial, especially for Lung-RADS category 4 nodules. Ultimately, additional investigations could lead to AI algorithms being used in a similar way to what has been suggested for screening mammography.”
Lung-RADS is a quality assurance tool designed to standardize lung cancer screening CT reporting and management recommendations, reduce confusion in lung cancer screening CT interpretations, and facilitate outcome monitoring. It is modeled on the success of the Breast Imaging Reporting and Data System (BI-RADS), with the primary goal of minimizing variation in the management of CT-detected lung nodules so that screening can be implemented effectively in radiology practices.
Related Links:
University of Saskatchewan
Researchers at the University of Saskatchewan (Saskatoon, Canada) conducted a study that performed secondary analysis of a known data set using an AI model developed by Google in 2019, and Lung-RADS classifications from six radiologists. They then compared them to assess a representative cohort of 3,197 baseline low-dose CT screening patients. To ensure the AI algorithm matched the 91% sensitivity level achieved by the providers, the researchers determined a 0.27 AI risk-score threshold, based on a 0-to-1 scale.
The results showed that the AI-informed management strategy achieved sensitivity and specificity of 91% and 96%, respectively, while the average sensitivity and specificity of the six radiologists using only Lung-RADS was 91% and 61%, respectively. Based on the AI management strategy, 0.2% of category 1 or 2 Lung-RADS classifications were upgraded to category 3, and 30% of category 3 or higher classifications were downgraded to category 2. The minimum net cost savings, based on 2019 U.S. Medicare physician fee schedule, was USD 72 per patient screened. The study was published on January 19, 2021, in Journal of the American College of Radiology.
“Using an AI risk score combined with Lung-RADS at baseline lung cancer screening may result in fewer follow-up investigations and substantial cost savings. Specificity could rise by more than fifty percent,” concluded lead author Scott Adams, MD, and colleagues. “Additional research for other AI thresholds could also beneficial, especially for Lung-RADS category 4 nodules. Ultimately, additional investigations could lead to AI algorithms being used in a similar way to what has been suggested for screening mammography.”
Lung-RADS is a quality assurance tool designed to standardize lung cancer screening CT reporting and management recommendations, reduce confusion in lung cancer screening CT interpretations, and facilitate outcome monitoring. It is modeled on the success of the Breast Imaging Reporting and Data System (BI-RADS), with the primary goal of minimizing variation in the management of CT-detected lung nodules so that screening can be implemented effectively in radiology practices.
Related Links:
University of Saskatchewan
Latest Radiography News
- AI Detection Tool Improves Identification of Lobular Breast Cancer
- New Contrast Agent Enables Low-Dose X-Ray Joint Imaging
- AI Boosts Breast Cancer Detection and Cuts Screening Workload
- AI Tool Predicts Breast Cancer Risk Years Ahead Using Routine Mammograms
- Routine Mammograms Could Predict Future Cardiovascular Disease in Women
- AI Detects Early Signs of Aging from Chest X-Rays
- X-Ray Breakthrough Captures Three Image-Contrast Types in Single Shot
- AI Generates Future Knee X-Rays to Predict Osteoarthritis Progression Risk
- AI Algorithm Uses Mammograms to Accurately Predict Cardiovascular Risk in Women
- AI Hybrid Strategy Improves Mammogram Interpretation
- AI Technology Predicts Personalized Five-Year Risk of Developing Breast Cancer
- RSNA AI Challenge Models Can Independently Interpret Mammograms
- New Technique Combines X-Ray Imaging and Radar for Safer Cancer Diagnosis
- New AI Tool Helps Doctors Read Chest X‑Rays Better
- Wearable X-Ray Imaging Detecting Fabric to Provide On-The-Go Diagnostic Scanning
- AI Helps Radiologists Spot More Lesions in Mammograms
Channels
MRI
view channel
MRI Tool Enables Long-Term Tracking of Transplanted Cardiac Cells
Cell therapies for myocardial injury face a persistent hurdle: clinicians cannot easily monitor whether transplanted cells survive and where they persist in the heart. This limits optimization of dosing,... Read more
MRI-Based AI Tool Supports Differentiation of Parkinsonian Syndromes
Clinicians often struggle to differentiate Parkinsonian syndromes at initial presentation, when symptom overlap can obscure disease trajectory and delay targeted care. Imaging markers derived from diffusion... Read more
MRI-Derived Biomarker Improves Risk Stratification in Glioblastoma
Glioblastoma is marked by rapid growth and diffuse infiltration that complicate prognosis and treatment planning. Clinicians need objective tools that capture both how these tumors expand and how they... Read more
Combined Imaging Approach Identifies Cause of Heart Attack without Coronary Blockage
Patients who present with myocardial infarction but show no obstructive coronary disease often leave without a definitive diagnosis. That uncertainty complicates in-hospital decision-making and post-discharge... Read moreUltrasound
view channel
Whole Cross-Section Ultrasound System Enables Operator-Independent Imaging
Conventional ultrasound is central to bedside imaging but is limited by a narrow field of view and operator variability. Comprehensive cross-sectional assessment typically requires computed tomography... Read more
New Ultrasound AI Tool Supports Rapid Prenatal Assessment
Accurate gestational age estimation guides prenatal screening, detection of complications, and timely intervention. Access to ultrasound and trained sonographers is uneven, with nearly half of U.... Read moreNuclear Medicine
view channelMR-Guided Cardiac Mapping System Enables Radiation-Free Procedures
Cardiac electrophysiology procedures are typically guided by X-ray fluoroscopy, which limits soft-tissue visualization and exposes patients and clinical staff to ionizing radiation. Real-time mapping that... Read more
PET Tracer Enables Noninvasive Measurement of Beta Cell Mass
Type 1 diabetes is an autoimmune disease in which the immune system destroys insulin-producing pancreatic beta cells. Loss of these cells destabilizes glucose control and drives complications.... Read more
New Imaging Tool Sheds Light on Tumor Fat Metabolism
Rapidly growing tumors reprogram metabolism to meet high energy demands. While many cancers preferentially consume glucose, lipid utilization by malignant cells is difficult to measure in living subjects.... Read more
Radiopharmaceutical Molecule Marker to Improve Choice of Bladder Cancer Therapies
Targeted cancer therapies only work when tumor cells express the specific molecular structures they are designed to attack. In urothelial carcinoma, a common form of bladder cancer, the cell surface protein... Read moreGeneral/Advanced Imaging
view channel
Routine Cardiac CT Enhanced to Predict Heart Failure Risk
Heart failure, a progressive inability of the heart to pump blood effectively, often develops silently before symptoms appear. Clinicians need reliable ways to detect myocardial injury early and stratify... Read more
New Breast Imaging Viewer Unifies Modalities and Enhances Clinical Workflow
Breast evaluation often requires correlating findings from mammography, digital breast tomosynthesis, MRI, ultrasound, and newer volumetric techniques. Switching between separate viewers to track changes... Read moreImaging IT
view channel
Breast Imaging Software Enhances Visualization and Tissue Characterization in Challenging Cases
Breast imaging can be particularly challenging in cases involving small breasts or implants, where image reconstruction and tissue characterization may be limited. Clinicians also need reproducible analysis... Read more
New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible
Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Global AI in Medical Diagnostics Market to Be Driven by Demand for Image Recognition in Radiology
The global artificial intelligence (AI) in medical diagnostics market is expanding with early disease detection being one of its key applications and image recognition becoming a compelling consumer proposition... Read moreIndustry News
view channel
Nuclear Medicine Set for Continued Growth Driven by Demand for Precision Diagnostics
Clinical imaging services face rising demand for precise molecular diagnostics and targeted radiopharmaceutical therapy as cancer and chronic disease rates climb. A new market analysis projects rapid expansion... Read more







